SV

Swaroop K. Vakkalanka

RA Rhizen Pharmaceuticals Ag: 8 patents #1 of 8Top 15%
Overall (2019): #12,555 of 560,194Top 3%
8
Patents 2019

Issued Patents 2019

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10442783 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases Meyyappan Muthuppalaniappan, Srikant Viswanadha, Govindarajulu Babu 2019-10-15
10413532 Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor Srikant Viswanadha 2019-09-17
10414773 Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations 2019-09-17
10322130 Substituted chromenones as modulators of protein kinases Dhanapalan Nagarathnam, Meyyappan Muthuppalaniappan, Srikant Viswanadha, Govindarajulu Babu, Prashant K. Bhavar 2019-06-18
10246450 Modulators of calcium release-activated calcium channel Meyyappan Muthuppalaniappan, Srikant Viswanadha, Gayatri S. Merikapudi 2019-04-02
10220035 Compounds as modulators of protein kinases Dhanapalan Nagarathnam, Meyyappan Muthuppalaniappan, Srikant Viswanadha, Govindarajulu Babu, Prashant K. Bhavar 2019-03-05
10179786 Selective dual inhibitors of PI3 delta and gamma protein kinases Prashant K. Bhavar 2019-01-15
10174034 Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer Meyyappan Muthuppalaniappan, Srikant Viswanadha, Kanthikiran V S Varansi, Gayatri S. Merikapudi 2019-01-08